[ET Net News Agency, 8 December 2025] REMEGEN (09995) fell 10.7% to HK$78.9.
It hits an intra-day low of HK$78.9, dipping below the 100-D SMA of HK$87.846, and an intra-day high of HK$89.25. The total shares traded was 4.19 million, with a value of HK$342.91m. The active buy/sell ratio is 30:70, with net selling turnover of HK$134.29m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$59.88m, with volume weighted average price of HK$81.854. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$20.81m, with volume weighted average price of HK$81.718. The stock has fallen a combined 12% over the past 2 consecutive trading days.
Basic Information| Nominal | 78.900 | % Chg | -10.70% |
| High | 89.250 | Low | 78.900 |
| Shares Tr | 4.19m | Turnover | 342.91m |
| 10-D SMA | 86.495 | %H.V | 53.128 |
| 20-D SMA | 84.902 | VWAP | 81.841 |
| 50-D SMA | 92.233 | RSI14 | 40.686 |
Status: Dipping below the 100-D SMA, active buy/sell ratio is 30:70, with net selling turnover of HK$134.29m, falling a combined 12% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| REMEGEN (09995) | 78.90 | -10.70 |
| SINO BIOPHARM (01177) | 6.82 | -0.29 |
| HENGRUI PHARMA (01276) | 73.90 | +0.27 |
| 3SBIO (01530) | 29.16 | -1.42 |
| EVEREST MED (01952) | 44.32 | -2.38 |
| KEYMED BIO-B (02162) | 58.20 | -1.52 |
| SKB BIO-B (06990) | 436.40 | -5.13 |
| DUALITYBIO-B (09606) | 327.20 | -2.62 |
| ZAI LAB (09688) | 15.35 | -1.67 |
| AKESO (09926) | 123.70 | -0.32 |
(ed)
